Skip to content

OptimizeRx OPRX Revenue share payable

Revenue share payable at other companies

Marqeta logo
MarqetaMQ
$35.62M+122%
PED
PEDEVCOPED
$22.95M+569%
Amplify Energy logo
Amplify EnergyAMPY
$7.51M-40.0%
Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
$75.73M+291%
IBT
IbottaIBTA
$106.29M+22.8%
Ring Energy logo
Ring EnergyREI
$37.16M+3.9%

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept oprx:RevenueSharePayableCurrent.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's revenue share payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's revenue share payable?
OptimizeRx (OPRX) reported revenue share payable of $955K in Q1 2026.
How has OptimizeRx's revenue share payable changed year-over-year?
OptimizeRx's revenue share payable decreased by 45.2% year-over-year, from $1.74M to $955K.
What is the long-term trend for OptimizeRx's revenue share payable?
Over 5 years (2020 to 2025), OptimizeRx's revenue share payable has grown at a -9.1% compound annual growth rate (CAGR), from $4.97M to $3.09M.
What does revenue share payable mean?
This represents the short-term financial obligation owed to partners or network participants based on agreed-upon revenue-sharing arrangements. It reflects the portion of revenue collected that must be distributed to third parties who facilitate the digital health messaging ecosystem. High or increasing levels may indicate significant reliance on external network partners to drive transaction volume.